Vaccine Innovation for Pandemic Preparedness: Patent Landscape, Global Sustainability, and Circular Bioeconomy in Post-COVID-19 era

Cristina Possas (), Adelaide Maria Souza Antunes, Alessandra Moreira Oliveira, Cristina d’Urso Souza Mendes Santos, Mateus Pinheiro Ramos, Suzanne Oliveira Rodrigues Schumacher and Akira Homma
Additional contact information
Cristina Possas: Oswaldo Cruz Foundation
Adelaide Maria Souza Antunes: Federal University of Rio de Janeiro
Alessandra Moreira Oliveira: Federal University of Rio de Janeiro
Cristina d’Urso Souza Mendes Santos: National Institute of Industrial Property
Mateus Pinheiro Ramos: Federal University of Rio de Janeiro
Suzanne Oliveira Rodrigues Schumacher: Federal University of Rio de Janeiro
Akira Homma: Oswaldo Cruz Foundation

Circular Economy and Sustainability, 2021, vol. 1, issue 4, 1439-1461

Abstract: Abstract In this article, we present breakthroughs and challenges in vaccine development for COVID-19 pandemic, discussing issues related to pandemic preparedness and their implications for circular bioeconomy and sustainability. Notwithstanding the unprecedented accelerated speed of COVID-19 vaccine development, just 9 months after the emergence of the pandemic in Wuhan, China, benefiting from previous developments in SARS and MERS vaccines, significant gaps persist in global vaccine preparedness. These gaps include issues related to immunity and protection, particularly to the limited vaccine protection against recent emergence of concerning new viral variants in the UK, South Africa, and Brazil and the consequent need for vaccine redesign. We examine these gaps and discuss the main issues that could impact on global vaccine availability in the current pandemic scenario: (1) breakthroughs and constraints in development and production of leading global COVID-19 vaccines; (2) innovation and technological development advances and gaps, providing information on global patent assignees for COVID-19, SARS, and MERS vaccine patents; (3) local capacity for development and production of COVID-19, SARS, and MERS vaccines in three emerging agro-based countries (India, Brazil, and South Africa); and (4) future scenarios, examining how these issues and vaccines redesign for new SARS-CoV-2 variants could impact on global access to vaccines and implications for circular bioeconomy and sustainability in the post-COVID era.

Keywords: Vaccine innovation; COVID-19; SARS; MERS; Pandemic preparedness; Circular economy (search for similar items in EconPapers)
Date: 2021
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s43615-021-00051-y Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:circec:v:1:y:2021:i:4:d:10.1007_s43615-021-00051-y

Ordering information: This journal article can be ordered from
https://www.springer.com/journal/43615

DOI: 10.1007/s43615-021-00051-y

Access Statistics for this article

More articles in Circular Economy and Sustainability from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().